Patients can be referred to clinical trials at the Feist-Weiller Cancer Center using the patient referral form.
Lists of current trials, both therapeutic and cancer prevention/control, can be accessed online.
If you have specific questions about eligibility, particulary inclusion and exclusion criteria, please ring the Clinical Research Office directly to get in touch with the CRA responsible for the study.
Feist-Weiller Cancer Center has been awarded status as a Minority-Based Community Clinical Oncology Program by the National Cancer Institute
The Community Clinical Oncology Program (CCOP) was established by the National Cancer Institite in 1983 to ensure that cancer patients have access to quality medical care in their own communities. In 1989, the NCI also approved the Minority-Based CCOP to increase the involvement of racial and ethnic minority patients in research, and increase their access to the latest advances in cancer treatment, prevention, and control.
Community Clinical Oncology Programs provide community physicians the opportunity to work with scientists and investigators at universities such as Louisiana State University Health Sciences Center-Shreveport to conduct National Cancer Institute supported clinical trials. This collaboration helps transfer the latest research findings to the community physicians and provide their patients the most up to date cancer care. The CCOPs also increase the number of patients and physicians who can participate in clinical trials allowing researchers to conduct large-scale cancer treatment, prevention, and control studies. In this way, questions about cancer care are answered more rapidly, and the latest research findings promptly distributed to communities.
The LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP will provide Feist-Weiller Cancer Center patients access to additional National Cancer Institute (NCI) clinical trials to determine the best therapies for cancer treatment, prevention, and treatment for the side effects of cancer therapies and symptoms of cancer. The Feist-Weiller Cancer Center has been an active participant in NCI clinical trials for over 20 years as a member of the South West Oncology Group (SWOG) and Clinical Trials Support Unit.
A major goal of the LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP is expansion of its Affilite Physician network to addition practices in northern and central Louisiana. Affiliate physicians will then be able to offer NCI clinical trials to their patients.
Physicians in Shreveport and central and northern Louisiana can participate in the Community Clinical Oncology Programs through affiliation with the Feist-Weiller Cancer Center MB-CCOP (FWCC MBCCOP).
Contact the FWCC MBCCOP Office at (318)813-1410 for information about becoming an affiliate.
We are actively participating in clinical trials and research for our cancer patients. Newly developed treatments or investigational drugs may reduce tumor size and eliminate symptoms better than treatments currently available.
Patients are asked if they would like to participate in our clinical trials to evaluate new cancer prevention and treatment choices. Participation is completely voluntary. Ask the doctor about clinical trials at your visit.
See the patient information on Clinical Trials at the Feist-Weiller Cancer Center. Additional information is available for medical professionals. For more information about ongoing clinical trials at the Feist-Weiller Cancer Center, please call us toll-free at 1-866-LSU-FWCC (578-3922) or (318) 813-1410.